IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value

$85.35+0.12 (+0.14%)

Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –

IRadimed EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

IRadimed's EV/EBITDA was 35.9× on Nov 11, 2026, against 43.7× a year earlier. Over the last 5 years it ranged from 19.2× to 58.7×, with a median of 29.8×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	35.9×	−9.8
2025	Dec 31, 2025	45.7×	+16.6
2024	Dec 31, 2024	29.1×	+0.0
2023	Dec 29, 2023	29.1×	+9.9
2022	Dec 30, 2022	19.2×	−39.5
2021	Dec 31, 2021	58.7×	−51.2
2020	Dec 31, 2020	109.9×	+85.7
2019	Dec 31, 2019	24.3×	−13.9
2018	Dec 31, 2018	38.1×	−8.9
2017	Dec 29, 2017	47.1×	+39.8
2016	Dec 30, 2016	7.3×	−27.0
2015	Dec 31, 2015	34.3×	+1.8
2014	Dec 31, 2014	32.4×	–